financetom
Business
financetom
/
Business
/
Steel giant Thyssenkrupp to leave Germany's DAX index
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Steel giant Thyssenkrupp to leave Germany's DAX index
Sep 4, 2019 10:46 PM

German steel giant Thyssenkrupp AG will have to leave Germany's benchmark DAX index on September 23, the Deutsche Boerse announced on Wednesday evening.

Share Market Live

NSE

Thyssenkrupp will be replaced by German aircraft engine manufacturer MTU Aero Engines AG, the Deutsche Boerse said. After its exit from the DAX, Thyssenkrupp will be included in the MDAX index, the Xinhua news agency reported.

In August, the German industrial giant with more than 200 years of history reported a pre-tax profit slump of 85 percent between April and June this year from the same period last year.

The benchmark DAX is a blue chip stock market index consisting of 30 major German companies trading on the Frankfurt Stock Exchange. The MDAX is the second stock market league consisting of 60 companies.

The DAX index closed 0.96 per cent higher at 12,025.04 on Wednesday. Stocks of Thyssenkrupp rose by 3.48 per cent to close at 11.00 Euros ($12.14) per share.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: G2 Goldfields Up 4.3% as It Sets Shareholder Meeting, Record Date, For Proposed G3 Spin-Out
Update: G2 Goldfields Up 4.3% as It Sets Shareholder Meeting, Record Date, For Proposed G3 Spin-Out
Nov 29, 2024
11:51 AM EST, 11/29/2024 (MT Newswires) -- G2 Goldfields ( GUYGF ) said Friday it filed the requisite notice to set the record and meeting date for a shareholders' meeting to vote on the company's proposed spinout of non-core assets. The record date to determine which shareholders are eligible to attend and vote at the meeting will be Dec. 17,...
Applied Therapeutics' Govorestat Faces 'Significant' Uncertainty in Galactosemia Treatment After FDA Rejection, RBC Says
Applied Therapeutics' Govorestat Faces 'Significant' Uncertainty in Galactosemia Treatment After FDA Rejection, RBC Says
Nov 29, 2024
12:15 PM EST, 11/29/2024 (MT Newswires) -- Applied Therapeutics' ( APLT ) lead drug candidate, govorestat, likely faces significant uncertainty in potentially treating galactosemia after the US Food and Drug Administration rejected the biopharmaceutical company's drug application, RBC Capital Markets said Friday. Late Wednesday, the clinical-stage company said the FDA is unable to approve govorestat's new drug application for the...
EU regulators scrap merger power aimed at killer acquisitions after court veto
EU regulators scrap merger power aimed at killer acquisitions after court veto
Nov 29, 2024
BRUSSELS (Reuters) - EU antitrust regulators on Friday ditched a merger tool aimed at killer acquisitions two months after Europe's top court vetoed this expanded merger power which had been widely criticised by companies as regulatory over-reach. The Luxembourg-based Court of Justice in September sided with Illumina ( ILMN ) in its fight against the European Commission's decision to wield...
EU regulators scrap merger power aimed at killer acquisitions after court veto
EU regulators scrap merger power aimed at killer acquisitions after court veto
Nov 29, 2024
BRUSSELS, Nov 29 (Reuters) - EU antitrust regulators on Friday ditched a merger tool aimed at killer acquisitions two months after Europe's top court vetoed this expanded merger power which had been widely criticised by companies as regulatory over-reach. The Luxembourg-based Court of Justice in September sided with Illumina ( ILMN ) in its fight against the European Commission's decision...
Copyright 2023-2026 - www.financetom.com All Rights Reserved